Dr. Kujtan on Frontline Therapy for EGFR-Positive NSCLC

preview_player
Показать описание

  1. OncLive
  2. cancer
  3. oncology
Рекомендации по теме
Dr. Kujtan on 0:01:23

Dr. Kujtan on Frontline Therapy for EGFR-Positive NSCLC

Copy of Dr. 0:00:26

Copy of Dr. Kujtan on Patient Preferences in the Treatment of NSCLC

Chemo + I-O 0:10:43

Chemo + I-O in Frontline mNSCLC: PD-L1 TPS 1%-49%

Treatment of EGFR+ 0:05:52

Treatment of EGFR+ NSCLC After Osimertinib

Dr. Konduri on 0:01:37

Dr. Konduri on Treatment Options for Patients With EGFR-Mutant NSCLC

Real world analysis 0:02:11

Real world analysis of second-line osimertinib use for NSCLC in North West London

Dr. Villaruz on 0:01:00

Dr. Villaruz on EGFR-Targeted Therapies in NSCLC

Dr. Reimuth Discusses 0:00:55

Dr. Reimuth Discusses Studies Looking at Resistance to EGFR TKIs in NSCLC

NSCLC: Integrating EGFR-Inhibiting 0:37:23

NSCLC: Integrating EGFR-Inhibiting Therapies into Clinical Pathways for First-Line Treatment

Advancing Care for 0:53:55

Advancing Care for Patients With EGFR Mutation–Positive NSCLC: Precision Medicine Strategies

GRACEcast- Dr. Sandip 0:06:44

GRACEcast- Dr. Sandip Patel- Emerging Molecular Targets in NSCLC- EGFR Exon 20